Victor Duenas-Fernandez
Barcelona, CT 08907, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Awakening Recovery: Enhancing Orexinergic Tone After Acute CNS Damage.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 10, 2025
The therapeutic use of music for chronic pain: a psychological and neurobiological perspective.
Journal: Frontiers in pain research (Lausanne, Switzerland)
Published: July 02, 2025
Dopamine dynamics in chronic pain: music-induced, sex-dependent, behavioral effects in mice.
Journal: Pain reports
Published: June 25, 2024
GPR37 processing in neurodegeneration: a potential marker for Parkinson's Disease progression rate.
Journal: NPJ Parkinson's disease
Published: February 11, 2024
Effect and safety of listening to music or audiobooks as a coadjuvant treatment for chronic pain patients under opioid treatment: a study protocol for an open-label, parallel-group, randomised, controlled, proof-of-concept clinical trial in a tertiary hospital in the Barcelona South Metropolitan area.
Journal: BMJ open
Published: September 11, 2023
Cannabidiol negatively modulates adenosine A2A receptor functioning in living cells.
Journal: Acta neuropsychiatrica
Published: August 22, 2023
Converging circuits between pain and depression: the ventral tegmental area as a therapeutic hub.
Journal: Frontiers in pharmacology
Published: August 15, 2023
Development of a Novel σ1 Receptor Biosensor Based on Its Heterodimerization with Binding Immunoglobulin Protein in Living Cells.
Journal: ACS chemical neuroscience
Published: May 16, 2023
Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists.
Journal: Journal of medicinal chemistry
Published: December 14, 2022
Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders.
Journal: Frontiers in pharmacology
Published: October 20, 2022
The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A1-A2A receptor heteromer formation and function.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 19, 2022
Last Updated: 09/26/2026